SS
PRVB

Simplicity Solutions’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Simplicity Solutions’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,221
Closed -$75K – 715
2022
Q1 		$75K Buy
+10,221
New +$61.1K 0.01% 613

Other funds holding PRVB

SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DCM
DG Capital Management New York $475M AUM 36.12% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Simplicity Solutions's PRVB Position: Q2 2022 in Review

Simplicity Solutions sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2022, closing a stake of 10,221 shares — an estimated $75K sold.

Simplicity Solutions first reported a position in PRVB in Q1 2022 and held it in 1 quarter. The position peaked at $75K in Q1 2022. 115 funds tracked by Wall St. Rank hold PRVB as of Q2 2022.

  • Simplicity Solutions reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Simplicity Solutions sold 10,221 Provention Bio, Inc. Common Stock shares in Q2 2022, an estimated $75K.
  • Simplicity Solutions first reported a position in Provention Bio, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Simplicity Solutions's Provention Bio, Inc. Common Stock position peaked at $75K in Q1 2022.
  • 115 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2022.

Based on Simplicity Solutions's 13F filing for Q2 2022, filed 19 Jul 2022.